Evolent Health Reaches Analyst Target Price

Shares of Evolent Health Inc. (EVH) crossed above the average analyst 12-month target price of $5.88, trading at $5.93 per share as noted by the article. It explains that when a stock reaches an analyst’s target, analysts typically either downgrade the valuation or reset their target higher, depending on business developments driving price gains. The piece states that 13 analysts in Zacks’ coverage contribute to the average, with one cited low target of $3.00 and a high target of $8.00, and a standard deviation of $1.325. The article frames the stock’s move past $5.88 as a prompt for investors to reassess whether valuation is extending. It adds that views in the report come from Zacks Investment Research data provided via Quandl.com.